Alerts in EHRs increase rates of HPV vaccine

The clinical reminder function within electronic health records (EHRs) could lead to more individuals receiving the human papillomavirus (HPV) vaccine, according to a study published in The American Journal of Managed Care.

Vaccinations are a first step in preventative medicine, yet patients continue to abstain from them later in life. In this study, researchers evaluated data from the 2007 – 2012 National Ambulatory Medical Care Survey to evaluate if EHR systems that include a clinical reminder function could lead to increased rates of HPV immunizations.

Evaluations of survey results showed that physicians with EHRs with clinical reminder functions were more likely to order HPV vaccines when compared to physicians without a reminder HER system. The reminders had the most effect in increasing HPV vaccinations rates among adolescent males.

“Overall, physicians who report using clinical reminders were more likely to order HPV immunizations,” concluded first author Jaeyong Bae, PhD and colleagues. “However, the association of clinical reminders with HPV immunizations was not significant in the younger adolescent subpopulation. Further, given that HPV incidence decreases significantly even with small gains in vaccination rates, the increase in HPV immunizations found in the male population aged 11 to 21 years is promising. Therefore, targeting males to receive HPV vaccination immunizations through clinical reminders provides a positively disproportionate return on vaccination rates and disease burden.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.